We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCTR icon
1401
Victory Capital Holdings
VCTR
$6.22B
$586K ﹤0.01%
23,637
-20,231
-46% -$414K
VTRU
1402
DELISTED
Vitru Limited Common Shares
VTRU
$586K ﹤0.01%
40,113
-1,058
-3% -$14.6K
LRCX icon
1403
Lam Research
LRCX
$331B
$585K ﹤0.01%
+12,390
New +$521K
SPOT icon
1404
Spotify
SPOT
$104B
$585K ﹤0.01%
+1,859
New +$525K
CLX icon
1405
Clorox
CLX
$12.2B
$583K ﹤0.01%
+2,885
New +$597K
GCP
1406
DELISTED
GCP Applied Technologies Inc.
GCP
$577K ﹤0.01%
24,381
-82,885
-77% -$1.93M
DNTH icon
1407
Dianthus Therapeutics
DNTH
$5.65B
$572K ﹤0.01%
4,563
BBT
1408
Beacon Financial Corp
BBT
$2.49B
$571K ﹤0.01%
+33,368
New +$498K
RYTM icon
1409
Rhythm Pharmaceuticals
RYTM
$7.45B
$570K ﹤0.01%
19,158
-9,034
-32% -$230K
ABM icon
1410
ABM Industries
ABM
$2.89B
$566K ﹤0.01%
14,954
-27,249
-65% -$1.03M
TECH icon
1411
Bio-Techne
TECH
$11.2B
$564K ﹤0.01%
7,108
-100,124
-93% -$7.25M
CYBR
1412
DELISTED
CyberArk
CYBR
$562K ﹤0.01%
3,481
-95,955
-96% -$11.2M
TMX
1413
DELISTED
Terminix Global Holdings, Inc.
TMX
$560K ﹤0.01%
10,976
-83,663
-88% -$4.04M
MPAA icon
1414
Motorcar Parts of America
MPAA
$265M
$556K ﹤0.01%
28,355
-6,673
-19% -$124K
UROV
1415
DELISTED
Urovant Sciences Ltd.
UROV
$556K ﹤0.01%
+34,494
New +$428K
KRRO icon
1416
Korro Bio
KRRO
$148M
$553K ﹤0.01%
+313
New +$413K
CYBE
1417
DELISTED
Cyberoptics Corp
CYBE
$550K ﹤0.01%
+24,237
New +$689K
GSAH.WS
1418
CALL
DELISTED
GS Acquisition Holdings Corp II Redeemable Warrants, each whole warrant exercisable for one share of
GSAH.WS
$544K ﹤0.01%
+49,994
New +$93.1K
BILI icon
1419
Bilibili
BILI
$7.59B
$541K ﹤0.01%
6,315
-39,377
-86% -$2.31M
RSI.WS
1420
CALL
DELISTED
Rush Street Interactive, Inc. Redeemable Warrants, each whole warrant exercisable for one share of C
RSI.WS
$541K ﹤0.01%
+24,999
New +$189K
LX
1421
LexinFintech Holdings
LX
$237M
$539K ﹤0.01%
+80,488
New +$576K
GNK icon
1422
Genco Shipping & Trading
GNK
$1.1B
$533K ﹤0.01%
+72,361
New +$527K
OZON
1423
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$533K ﹤0.01%
+12,336
New +$538K
PLYM
1424
DELISTED
Plymouth Industrial REIT
PLYM
$531K ﹤0.01%
35,379
-177,455
-83% -$2.37M
SAFM
1425
DELISTED
Sanderson Farms Inc
SAFM
$531K ﹤0.01%
+4,018
New +$530K

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.